EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modulating miRNA-367-3p Expression by Kaempferol Alleviates Experimental Autoimmune Encephalomyelitis: Targeting Fpn1-Dependent Ferroptosis and cAMP/CREB/CNTF Signaling

Rehab M El-Gohary, Heba M Shoeib, Ramez A E Barhoma, Shimaa M Badr, Shaimaa Mohammed Zaher, Rehab E Abo El Gheit iD, Ola A Elshora, Mona H Elamly, Mostafa Rizk Magar, Gamaleldien Elsayed Abdelkader, Asmaa S Mohamed iD

Neurochemical Research · 2026

DOI: 10.1007/s11064-025-04641-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemical Research, 2026. Verfasst von Rehab M El-Gohary und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical Biochemistry Department, Faculty of Medicine, Tanta University, Tanta, 31527, Egypt. Rehab.elgohary@med.tanta.edu.eg. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Kaempferols, MicroRNAs, Cation Transport Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tanta University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) is a progressive, immune-mediated demyelinating disorder of the central nervous system (CNS). Kaempferol (KAM), a dietary bioflavonoid found in many edible and medicinal plants, exhibits significant neuroprotective effects in various immunological and neurological disorders; however, its therapeutic potential in MS remains largely unexplored. This study aimed to investigate the protective effects of KAM and the underlying molecular mechanisms using an experimental autoimmune encephalomyelitis (EAE) mouse model of MS. 40 female C57B1/6 mice were assigned to 4 groups: Normal control [saline (i.d.) + DMSO (i.p.)]; KAM [saline (i.d.) + KAM (50 mg/kg/d, i.p.)]; EAE [MOG 35–55 immunization (i.d.) + DMSO (i.p.)]; and EAE + KAM [MOG 35–55 immunization (i.d.) + KAM (50 mg/kg/d, i.p.)]. The brain and spinal cord were dissected for biochemical, molecular, histopathological, electron microscopic, and immunohistochemical analysis. KAM administration efficiently reduced clinical scores and ameliorated neural cytomorphological abnormalities. KAM profoundly combated iron overload and effectively upregulated ferroportin1 (Fpn1)-encoding gene expression. Furthermore, KAM valuably counteracted neuronal ferroptosis chiefly by restoring the Slc7A11/GSH/GPX4 axis. KAM considerably attenuated proinflammatory cytokine IL-17 and chemokine CCL-19. Intriguingly, KAM promoted axonal remyelination as indicated by an observable escalation in myelin basic protein content through activating the cAMP/CREB/ciliary neurotrophic factor (CNTF) axis. Collectively, for the first time, these findings demonstrated KAM’s neuroprotective potency against EAE, considering its antioxidant, anti-ferroptotic, immunomodulatory, anti-inflammatory, and neurotrophic properties, primarily mediated by inhibiting Fpn1-mediated ferroptosis, activating the cAMP/CREB/CNTF axis, and enhancing miRNA-367-3p expression. Accordingly, miRNA-367-3p has been proposed as an upcoming therapeutic target for MS, and KAM could be a promising treatment option for MS patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalomyelitis, Autoimmune, ExperimentalKaempferolsMicroRNAsCation Transport ProteinsFerroptosisAnimalsFemaleMiceMice, Inbred C57BLSignal TransductionCiliary Neurotrophic FactorCyclic AMPFerroportinCyclic AMP Response Element-Binding ProteinNeuroprotective AgentsSpinal Cord

Stichwörter der Autor:innen

Ciliary neurotrophic factorFerroportin1FerroptosisKaempferolMultiple sclerosismiRNA-367-3P

Substanzen

KaempferolsMicroRNAsCation Transport ProteinskaempferolCiliary Neurotrophic FactorCyclic AMPFerroportinCyclic AMP Response Element-Binding ProteinCreb1 protein, mouseNeuroprotective Agents

Autor:innen und Institutionen

  • Medical Biochemistry Department, Faculty of Medicine, Tanta University, Tanta, 31527, Egypt. Rehab.elgohary@med.tanta.edu.eg.
  • Medical Biochemistry Department, Faculty of Medicine, Tanta University, Tanta, 31527, Egypt.
  • Medical Physiology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Department of Restorative Dentistry and Basic Medical Sciences, Faculty of Dentistry, University of Petra, Amman, 11196, Jordan.
  • Histology and cell biology department, Faculty of medicine, Tanta University, Tanta, Egypt.
  • Histology and cytology department, Faculty of medicine, Helwan University, Cairo, Egypt.

ORCID-Profile: Rehab E Abo El Gheit, Asmaa S Mohamed

Förderung

  • Tanta University

Zitieren

APA

El-Gohary, R. M., Shoeib, H. M., Barhoma, R. A. E., Badr, S. M., Zaher, S. M., El Gheit, R. E. A., Elshora, O. A., Elamly, M. H., Magar, M. R., Abdelkader, G. E., & Mohamed, A. S. (2026). Modulating miRNA-367-3p Expression by Kaempferol Alleviates Experimental Autoimmune Encephalomyelitis: Targeting Fpn1-Dependent Ferroptosis and cAMP/CREB/CNTF Signaling. Neurochemical Research. https://doi.org/10.1007/s11064-025-04641-2

Vancouver

El-Gohary RM, Shoeib HM, Barhoma RAE, Badr SM, Zaher SM, El Gheit REA, et al. Modulating miRNA-367-3p Expression by Kaempferol Alleviates Experimental Autoimmune Encephalomyelitis: Targeting Fpn1-Dependent Ferroptosis and cAMP/CREB/CNTF Signaling. Neurochemical Research. 2026. doi:10.1007/s11064-025-04641-2

BibTeX
@article{ElGohary2026,
  author = {El-Gohary, Rehab M and Shoeib, Heba M and Barhoma, Ramez A E and Badr, Shimaa M and Zaher, Shaimaa Mohammed and El Gheit, Rehab E Abo and Elshora, Ola A and Elamly, Mona H and Magar, Mostafa Rizk and Abdelkader, Gamaleldien Elsayed and Mohamed, Asmaa S},
  title = {Modulating miRNA-367-3p Expression by Kaempferol Alleviates Experimental Autoimmune Encephalomyelitis: Targeting Fpn1-Dependent Ferroptosis and cAMP/CREB/CNTF Signaling},
  journal = {Neurochemical Research},
  year = {2026},
  doi = {10.1007/s11064-025-04641-2}
}
Kostenlos starten →